These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 27382179)
1. Resistance mutations generate divergent antibiotic susceptibility profiles against translation inhibitors. Cocozaki AI; Altman RB; Huang J; Buurman ET; Kazmirski SL; Doig P; Prince DB; Blanchard SC; Cate JH; Ferguson AD Proc Natl Acad Sci U S A; 2016 Jul; 113(29):8188-93. PubMed ID: 27382179 [TBL] [Abstract][Full Text] [Related]
2. Negamycin induces translational stalling and miscoding by binding to the small subunit head domain of the Escherichia coli ribosome. Olivier NB; Altman RB; Noeske J; Basarab GS; Code E; Ferguson AD; Gao N; Huang J; Juette MF; Livchak S; Miller MD; Prince DB; Cate JH; Buurman ET; Blanchard SC Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16274-9. PubMed ID: 25368144 [TBL] [Abstract][Full Text] [Related]
3. Negamycin interferes with decoding and translocation by simultaneous interaction with rRNA and tRNA. Polikanov YS; Szal T; Jiang F; Gupta P; Matsuda R; Shiozuka M; Steitz TA; Vázquez-Laslop N; Mankin AS Mol Cell; 2014 Nov; 56(4):541-50. PubMed ID: 25306922 [TBL] [Abstract][Full Text] [Related]
4. In vitro ribosome synthesis and evolution through ribosome display. Hammerling MJ; Fritz BR; Yoesep DJ; Kim DS; Carlson ED; Jewett MC Nat Commun; 2020 Feb; 11(1):1108. PubMed ID: 32111839 [TBL] [Abstract][Full Text] [Related]
5. The contribution of common rpsL mutations in Escherichia coli to sensitivity to ribosome targeting antibiotics. Pelchovich G; Schreiber R; Zhuravlev A; Gophna U Int J Med Microbiol; 2013 Dec; 303(8):558-62. PubMed ID: 23972615 [TBL] [Abstract][Full Text] [Related]
6. Mapping of the second tetracycline binding site on the ribosomal small subunit of E.coli. Anokhina MM; Barta A; Nierhaus KH; Spiridonova VA; Kopylov AM Nucleic Acids Res; 2004; 32(8):2594-7. PubMed ID: 15141029 [TBL] [Abstract][Full Text] [Related]
7. Improving on nature: antibiotics that target the ribosome. Sutcliffe JA Curr Opin Microbiol; 2005 Oct; 8(5):534-42. PubMed ID: 16111914 [TBL] [Abstract][Full Text] [Related]
8. The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Brodersen DE; Clemons WM; Carter AP; Morgan-Warren RJ; Wimberly BT; Ramakrishnan V Cell; 2000 Dec; 103(7):1143-54. PubMed ID: 11163189 [TBL] [Abstract][Full Text] [Related]
9. Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibiotic. Grossman TH; Starosta AL; Fyfe C; O'Brien W; Rothstein DM; Mikolajka A; Wilson DN; Sutcliffe JA Antimicrob Agents Chemother; 2012 May; 56(5):2559-64. PubMed ID: 22354310 [TBL] [Abstract][Full Text] [Related]
10. Isolation of antibiotic resistance mutations in the rRNA by using an in vitro selection system. Cochella L; Green R Proc Natl Acad Sci U S A; 2004 Mar; 101(11):3786-91. PubMed ID: 15001709 [TBL] [Abstract][Full Text] [Related]
11. Structural analysis of kasugamycin inhibition of translation. Schuwirth BS; Day JM; Hau CW; Janssen GR; Dahlberg AE; Cate JH; Vila-Sanjurjo A Nat Struct Mol Biol; 2006 Oct; 13(10):879-86. PubMed ID: 16998486 [TBL] [Abstract][Full Text] [Related]
12. Erythromycin- and chloramphenicol-induced ribosomal assembly defects are secondary effects of protein synthesis inhibition. Siibak T; Peil L; Xiong L; Mankin A; Remme J; Tenson T Antimicrob Agents Chemother; 2009 Feb; 53(2):563-71. PubMed ID: 19029332 [TBL] [Abstract][Full Text] [Related]